190 related articles for article (PubMed ID: 24130088)
1. Long-term follow-up after autologous skeletal myoblast transplantation in ischaemic heart disease.
Brickwedel J; Gulbins H; Reichenspurner H
Interact Cardiovasc Thorac Surg; 2014 Jan; 18(1):61-6. PubMed ID: 24130088
[TBL] [Abstract][Full Text] [Related]
2. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.
Menasché P; Alfieri O; Janssens S; McKenna W; Reichenspurner H; Trinquart L; Vilquin JT; Marolleau JP; Seymour B; Larghero J; Lake S; Chatellier G; Solomon S; Desnos M; Hagège AA
Circulation; 2008 Mar; 117(9):1189-200. PubMed ID: 18285565
[TBL] [Abstract][Full Text] [Related]
3. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
Henry TD; Pepine CJ; Lambert CR; Traverse JH; Schatz R; Costa M; Povsic TJ; David Anderson R; Willerson JT; Kesten S; Perin EC
Catheter Cardiovasc Interv; 2017 Feb; 89(2):169-177. PubMed ID: 27148802
[TBL] [Abstract][Full Text] [Related]
4. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.
Menasché P; Hagège AA; Vilquin JT; Desnos M; Abergel E; Pouzet B; Bel A; Sarateanu S; Scorsin M; Schwartz K; Bruneval P; Benbunan M; Marolleau JP; Duboc D
J Am Coll Cardiol; 2003 Apr; 41(7):1078-83. PubMed ID: 12679204
[TBL] [Abstract][Full Text] [Related]
5. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients.
Hagège AA; Marolleau JP; Vilquin JT; Alhéritière A; Peyrard S; Duboc D; Abergel E; Messas E; Mousseaux E; Schwartz K; Desnos M; Menasché P
Circulation; 2006 Jul; 114(1 Suppl):I108-13. PubMed ID: 16820558
[TBL] [Abstract][Full Text] [Related]
6. Skeletal myoblast transplantation: no MAGIC bullet for ischemic cardiomyopathy.
Eisen HJ
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):520-1. PubMed ID: 18648335
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
[TBL] [Abstract][Full Text] [Related]
8. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
[TBL] [Abstract][Full Text] [Related]
9. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up.
Smits PC; van Geuns RJ; Poldermans D; Bountioukos M; Onderwater EE; Lee CH; Maat AP; Serruys PW
J Am Coll Cardiol; 2003 Dec; 42(12):2063-9. PubMed ID: 14680727
[TBL] [Abstract][Full Text] [Related]
10. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
[TBL] [Abstract][Full Text] [Related]
11. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
[TBL] [Abstract][Full Text] [Related]
12. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up.
Gavira JJ; Herreros J; Perez A; Garcia-Velloso MJ; Barba J; Martin-Herrero F; Cañizo C; Martin-Arnau A; Martí-Climent JM; Hernández M; López-Holgado N; González-Santos JM; Martín-Luengo C; Alegria E; Prósper F
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):799-804. PubMed ID: 16580437
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
[TBL] [Abstract][Full Text] [Related]
14. [Percutaneous transplantation of autologous myoblasts in ischemic cardiomyopathy].
Ince H; Petzsch M; Rehders TC; Kische S; Chatterjee T; Nienaber CA
Herz; 2005 May; 30(3):223-31. PubMed ID: 15902373
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcome of Intra-Myocardial Injection of Autologous Bone Marrow Mononuclear Cells Combined with Isolated Coronary Artery Bypass Grafting for Patients with Chronic Ischemic Heart Failure.
Wang R; Zhang L; Wang Y; Gong Z; Xiao C; Wu Y; Ren C; Cheng N; Gao C
Heart Surg Forum; 2016 Jun; 19(3):E131-8. PubMed ID: 27355149
[TBL] [Abstract][Full Text] [Related]
16. Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial.
Forcillo J; Stevens LM; Mansour S; Prieto I; Salem R; Baron C; Roy DC; Larose E; Masckauchan D; Noiseux N
Can J Cardiol; 2013 Apr; 29(4):441-7. PubMed ID: 23265095
[TBL] [Abstract][Full Text] [Related]
17. Improved clinical course of autologous skeletal myoblast sheet (TCD-51073) transplantation when compared to a propensity score-matched cardiac resynchronization therapy population.
Imamura T; Kinugawa K; Sakata Y; Miyagawa S; Sawa Y; Yamazaki K; Ono M
J Artif Organs; 2016 Mar; 19(1):80-6. PubMed ID: 26267666
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study.
Pokushalov E; Romanov A; Chernyavsky A; Larionov P; Terekhov I; Artyomenko S; Poveshenko O; Kliver E; Shirokova N; Karaskov A; Dib N
J Cardiovasc Transl Res; 2010 Apr; 3(2):160-8. PubMed ID: 20560030
[TBL] [Abstract][Full Text] [Related]
19. Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy.
Veltman CE; Soliman OI; Geleijnse ML; Vletter WB; Smits PC; ten Cate FJ; Jordaens LJ; Balk AH; Serruys PW; Boersma E; van Domburg RT; van der Giessen WJ
Eur Heart J; 2008 Jun; 29(11):1386-96. PubMed ID: 18441322
[TBL] [Abstract][Full Text] [Related]
20. Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure.
Qayyum AA; Mouridsen M; Nilsson B; Gustafsson I; Schou M; Nielsen OW; Hove JD; Mathiasen AB; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Haack-Sørensen M; Ekblond A; Kastrup J
ESC Heart Fail; 2023 Apr; 10(2):1170-1183. PubMed ID: 36638837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
